Company
Micro-Tech
Headquarters: Nanjing, China
Market Cap
CN¥13.09 Billion
CNY as of Jan. 1, 2025
US$1.79 Billion
Micro-Tech Categories
China Healthcare Medical Instruments & SuppliesChina Healthcare China Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Micro-Tech (Nanjing) Co., Ltd. manufactures and sells non-vascular stents and disposable biopsy forceps primarily in China, Europe, North America, Oceania, etc. The company offers gastroenterology products, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, cytology brushes, retrieval devices, and accessories. The company also offers OEM/ODM services to companies in the medical devices field. Micro-Tech (Nanjing) Co., Ltd. was founded in 1999 and is based in Nanjing, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥2.68 B |
| EBITDA | CN¥700.3 M |
| Gross Profit TTM | CN¥1.76 B |
| Profit Margin | 20.55% |
| Operating Margin | 25.51% |
| Quarterly Revenue Growth | 13.40% |
Stocks & Indices
Micro-Tech has the following listings and related stock indices.
Stock: SSE: 688029 wb_incandescent